Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 2, 2025Clinical & Experimental AllergyOpen Access

Real‐World Effectiveness and Safety of JAK Inhibitors in Atopic Dermatitis: A Systematic Review and Meta‐Analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

YKY.H. KimGSGayeong SeoJKJacob J.E. Koopman

Discussion

Loading...

Member takes

Overview

Systematic review evaluates effectiveness and safety of JAK inhibitors in atopic dermatitis, indicating real-world outcomes align with clinical trials.

Key Points

  • Core contribution reveals that JAK inhibitors demonstrate effectiveness in treating moderate to severe atopic dermatitis.
  • Data shows pooled effectiveness estimates of EASI-75 reaching 86% at 52 weeks, indicating strong treatment response.
  • Systematic review included 50 studies from real-world settings assessing JAK inhibitors' safety and effectiveness.
  • Findings suggest that real-world efficiency of JAK inhibitors is comparable to results obtained from clinical trials.

Cite This Study

Kim et al. (2025) studied this question.

synapsesocial.com/papers/689a0c72e6551bb0af8d0420https://doi.org/10.1111/cea.70125
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched one closely related paper. Consider it for comparative context:

  1. 1Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials2020 · 149 citations